The DOI matches its Crossref record.
Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral Ischemia
Abstract
BACKGROUND: Dexmedetomidine, a highly selective alpha 2-adrenoreceptor agonist, decreases central sympathetic activity and reduces the anesthetic requirement of halothane. Preliminary studies show that dexmedetomidine improves the outcome from ischemic injury and, therefore, may have potential therapeutic value. METHODS: The authors studied 14 rabbits that underwent a 2-h occlusion of the left internal carotid, anterior cerebral, and middle cerebral arteries, followed by 4 h of reperfusion. Ten minutes after occlusion, the animals were treated with either normal saline (n = 7) or dexmedetomidine (n = 7) using a computer-controlled infusion rate calculated to maintain a steady state plasma concentration. Halothane concentration was reduced by 50% for dexmedetomidine-treated animals to maintain a comparable level of anesthesia. Somatosensory evoked potentials were used to confirm adequate ischemia, and injury was assessed by histopathology. RESULTS: There were significant differences in the area of ischemic neuronal damage between the groups in the cortex (halothane alone, 38.2 +/- 6.0% SEM vs. halothane plus dexmedetomidine, 20.0 +/- 2.7% SEM, P = 0.018), but not in the striatum (halothane alone, 68.7 +/- 12.6% SEM vs. halothane plus dexmedetomidine, 43.5 +/- 15.9% SEM, P = 0.24), nor in physiologic parameters. Dexmedetomidine plasma levels obtained every 90 min showed a mean of 4.0 +/- 0.15 ng/ml. CONCLUSIONS: Results from this study indicate that postischemic administration of dexmedetomidine, in a dose that reduces the anesthetic requirements by 50%, has a neuroprotective effect in this model of focal cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role
Khan, Z. P., Ferguson, C. N., & Jones, R. M. (1999) · Anaesthesia · doi:10.1046/j.1365-2044.1999.00659.x · Cited by 686
Very Delayed Infarction after Mild Focal Cerebral Ischemia: A Role for Apoptosis?
Du, C., Hu, R., Csernansky, C. A., Hsu, C. Y., & Choi, D. W. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199603000-00003 · Cited by 600
Dexmedetomidine and the Reduction of Postoperative Delirium after Cardiac Surgery
Maldonado, J. R., Wysong, A., van der Starre, P. J. A., Block, T., Miller, C., & Reitz, B. A. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.3.206 · Cited by 460
Krupin, T., Liebmann, J. M., Greenfield, D. S., Ritch, R., & Gardiner, S. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.09.026 · Cited by 394
Abdallah, F. W., & Brull, R. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet066 · Cited by 347
Metadata
- Authors
- Maier, C., Steinberg, G. K., Sun, G. H., Zhi, G. T., & Maze, M.
- Venue
- Anesthesiology
- Published
- 1993-08-01
- Volume
- 79
- Issue
- 2
- Pages
- 306-312
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2169341893
- Cited by
- 234
- References
- 0
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral Ischemia. https://app.cochat.ai/papers/10.1097/00000542-199308000-00016
- The paper
- Maier, C., Steinberg, G. K., Sun, G. H., Zhi, G. T., & Maze, M. (1993). Neuroprotection by the α2-Adrenoreceptor Agonist Dexmedetomidine in a Focal Model of Cerebral Ischemia. Anesthesiology. https://doi.org/10.1097/00000542-199308000-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.